The relationship between the interferon α response and viral burden in primary SIV infection

AIDS Research and Human Retroviruses

Volumn 12, Issue 13, 1996, Pages 1273-1275

  Khatissian, Emmanuel ^a   Tovey, Michael G ^b   Cumont, Marie Christine ^a   Monceaux, Valerie ^a   Lebon, Pierre ^c   Montagnier, Luc ^a   Hurtrel, Bruno ^a   Chakrabarti, Lisa ^a  

^a INSTITUT PASTEUR   (France)

^b CNRS   (France)

^c HÔPITAL SAINT VINCENT DE PAUL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON;

ADOLESCENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; IMMUNE RESPONSE; LYMPH NODE; MONKEY DISEASE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RHESUS MONKEY; SIMIAN IMMUNODEFICIENCY VIRUS; VIRUS INFECTION; VIRUS REPLICATION;

EID: 0029817938     PISSN: 08892229     EISSN: None     Source Type: Journal    
DOI: 10.1089/aid.1996.12.1273     Document Type: Article

References (32)

1. Gresser I, Tovey MG, Maury C, and Bandu MT: Role of interferon in the pathogenesis of virus diseases in mice as demonstrated by the use of anti-interferon serum. II. Studies with herpes simplex, Moloney sarcoma, vesicular stomatitis, Newcastle disease, and influenza viruses. J Exp Med 1976;144:1316-1323.
2. Dalton DK, Pitts MS, Keshav S, Figari IS, Bradley A, and Stewart TA: Multiple defects of immune cell function in mice with disrupted interferon-gamma genes. Science 1993;259:1739-1742. [See comments].
3. Müller U, Steinhoff U, Reis LF, Hemmi S, Pavlovic J, Zinkernagel RM, and Aguet M: Functional role of type I and type II interferons in antiviral defense. Science 1994;264:1918-1921.
4. Baron S and Dianzani F: The interferons: A biological system with therapeutic potential in viral infections. Antiviral Res 1994; 24:97-110.
5. Pitha PM: Multiple effects of interferon on the replication of human immunodeficiency virus type 1. Antiviral Res 1994;24:205-219.
6. Poli G, Biswas P, and Fauci AS: Interferons in the pathogenesis and treatment of human immunodeficiency virus infection. Antiviral Res 1994;24:221-233.
7. Gaines H, von Sydow MA, von Stedingk LV, Biberfeld G, Böttiger B, Hansson LO, Lundbergh P, Sönnerborg AB, Wasserman J, and Strannegard ÖO: Immunological changes in primary HIV-1 infection. AIDS 1990;4:995-999.
8. von Sydow M, Sönnerborg A, Gaines H, and Strannegard Ö: Interferon-alpha and tumor necrosis factor-alpha in serum of patients in various stages of HIV-1 infection. AIDS Res Hum Retroviruses 1991;7:375-380.
9. Künzi M, Farzadegan H, Margolick J, Vlahov D, and Pitha P: Identification of human immunodeficiency virus primary isolates resistant to interferon-alpha and correlation of prevalence to disease progression. J Infect Dis 1995;171:822-828.
10. Daniel MD, Letvin NL, King NW, Kannagi M, Sehgal PK, Hunt RD, Kanki PJ, Essex M, and Desrosiers RC: Isolation of a T-cell tropic HTLVIII-like retrovirus from macaques. Science 1985;228: 1201-1204.
11. Chakrabarti L, Guyader M, Alizon M, Daniel MD, Desrosiers RC, Tiollais P, and Sonigo P: Sequence of simian immunodeficiency virus from macaque and its relationship to other human and simian retroviruses. Nature (London) 1987;328:543-547.
12. Desrosiers RC: The simian immunodeficiency viruses. Annu Rev Immunol 1990;8:557-578.
13. Letvin NL and King NW: Immunologic and pathologic manifestations of the infection of rhesus monkeys with simian immunodeficiency virus of macaques. J Acquir Immune Defic Syndr 1990;3:1023-1040.
14. Hirsch VM and Johnson PR: Pathogenic diversity of simian immunodeficiency viruses. Virus Res 1994;32:183-203.
15. Wyand MS, Ringler DJ, Naidu YM, Mattmuller M, Chalifoux LV, Sehgal PK, Daniel MD, Desrosiers RC, and King NW: Cellular localization of simian immunodeficiency virus in lymphoid tissues. II. In situ hybridization. Am J Pathol 1989;134:385-393.
16. Ringler DJ, Wyand MS, Walsh DG, Mackey JJ, Chalifoux LV, Popovic M, Minassian AA, Sehgal PK, Daniel MD, Desrosiers RC, and King NW: Cellular localization of simian immunodeficiency virus in lymphoid tissues. Am J Pathol 1989;134:373-383.
17. Chakrabarti L, Isola P, Cumont MC, Claessens-Maire MA, Hurtrel M, Montagnier L, and Hurtrel B: Early stages of SIV infection in lymph nodes: Evidence for high viral load and successive populations of target cells. Am J Pathol 1994;144:1226-1237.
18. Lackner AA, Vogel P, Ramos RA, Kluge JD, and Marthas M: Early events in tissues during infection with pathogenic (SIVmac239) and nonpathogenic (SIVmac1A11) molecular clones of simian immunodeficiency virus. Am J Pathol 1994;145:428-439.
19. Reimann KA, Tenner-Racz K, Racz P, Montefiori DC, Yasutomi Y, Lin W, Ransil BJ, and Letvin NL: Immunopathogenic events in acute infection of rhesus monkeys with simian immunodeficiency virus of macaques. J Virol 1994;68:2362-2370.
20. Baskin GB, Martin LN, Murphey-Corb M, Hu F-S, Kuebler D, and Davison B: Distribution of SIV in lymph nodes of serially sacrificed rhesus monkeys. AIDS Res Hum Retroviruses 1995;11:273-285.
21. Chakrabarti L, Cumont MC, Montagnier L, and Hurtrel B: Variable course of primary simian immunodeficiency virus infection in lymph nodes: Relation to disease progression. J Virol 1994;68:6634-6642.
22. Kornfeld H, Riedel N, Viglianti G, Hirsch VM, and Mullins JI: Cloning of HTLV-4 and its relation to simian and human immunodeficiency viruses. Nature (London) 1987;326:610-613.
23. Israel ZR, Edmonson PF, Maul DH, O'Neil SP, Mossman S, P, Thiriart C, Fabry L, Van Opstal O, Bruck C, Bex F, Burny A, Fultz PN, Mullins JI, and Hoover EA: Incomplete protection, but suppression of virus burden, elicited by subunit simian immunodeficiency virus vaccines. J Virol 1994;68:1843-1853.
24. Gresser I, Bandu MT, Brouty-boye D, and Tovey M: Pronounced antiviral activity of human interferon on bovine and porcine cells. Nature (London) 1974;251:543-545.
25. Yonehara S, Yonehara-Takahashi M, and Ishii A: Binding of human interferon alpha to cells of different sensitivities: Studies with internally radiolabeled interferon retaining full biological activity. J Virol 1983;45:1168-1171.
26. Singer RH, Lawrence JB, and Rashtchian RN: Toward a rapid and sensitive hybridization methodology using isotopic and non isotopic probes. In: In Situ Hybridization: Application to Neurobiology (Valentino KL, Eberwine JH, and Barchas JD, eds.). Oxford University Press, New York, 1987, pp. 71-96.
27. Chakrabarti L, Baptiste V, Khatissian E, Cumont MC, Aubertin AM, Montagnier L, and Hurtrel B: Limited viral spread and rapid immune response in lymph nodes of macaques inoculated with attenuated simian immunodeficiency virus. Virology 1995;213:535-548.
28. von Herrath M, Oldstone MB, and Fox HS: Simian immunodeficiency virus (SIV)-specific CTL in cerebrospinal fluid and brains of SIV-infected rhesus macaques. J Immunol 1995;154:5582-5589.
29. Gendelman HE, Friedman RM, Joe S, Baca LM, Turpin JA, Dveksler G, Meltzer MS, and Dieffenbach C: A selective defect of interferon alpha production in human immunodeficiency virus-infected monocytes. J Exp Med 1990;172:1433-1442.
30. D'Addario M, Roulston A, Wainberg MA, and Hiscott J: Coordinate enhancement of cytokine gene expression in human immunodeficiency virus type 1-infected promonocytic cells. J Virol 1990;64:6080-6089.
31. Rossol S, Voth R, Laubenstein HP, Muller WE, Schroder HC, Meyer zum Buschenfelde KH, and Hess G: Interferon production in patients infected with HIV-1. J Infect Dis 1989;159:815-821.
32. Roy S, Katze MG, Parkin NT, Edery I, Hovanessian AG, and Sonenberg N: Control of the interferon-induced 68-kilodalton protein kinase by the HIV-1 tat gene product. Science 1990;247: 1216-1219.